Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug

Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study

(2012) M. N. Saleh et al.   BLOOD

How I treat acquired aplastic anemia

(2012) P. Scheinberg et al.   BLOOD

Favorable outcome of patients who have 13q deletion: a suggestion for revision of the WHO 'MDS-U' designation

(2012) K. Hosokawa et al.   HAEMATOLOGICA

Leukemic transformation in patients with myelodysplastic syndromes after treatment with granulocyte colony-stimulating factor

(2012) Panagiotis T. Diamantopoulos et al.   LEUKEMIA & LYMPHOMA

Eltrombopag and Improved Hematopoiesis in Refractory Aplastic Anemia

(2012) Matthew J. Olnes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Eltrombopag, a thrombopoietin receptor agonist, enhances human umbilical cord blood hematopoietic stem/primitive progenitor cell expansion and promotes multi-lineage hematopoiesis

(2012) Hongliang Sun et al.   Stem Cell Research

A randomized controlled study in patients with newly diagnosed severe aplastic anemia receiving antithymocyte globulin (ATG), cyclosporine, with or without G-CSF: a study of the SAA Working Party of the European Group for Blood and Marrow Transplantation

(2011) A. Tichelli et al.   BLOOD

SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes

(2011) M. G. Afable et al.   BLOOD

Decreased Infection-Related Mortality and Improved Survival in Severe Aplastic Anemia in the Past Two Decades

(2011) J. M. Valdez et al.   CLINICAL INFECTIOUS DISEASES

Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia

(2011) M. G. Afable et al.   HAEMATOLOGICA

Horse versus Rabbit Antithymocyte Globulin in Acquired Aplastic Anemia

(2011) Phillip Scheinberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparative genomic hybridization on microarray (a-CGH) in constitutional and acquired mosaicism may detect as low as 8% abnormal cells

(2011) Roberto Valli et al.   Molecular Cytogenetics

Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes

(2010) X. Feng et al.   HAEMATOLOGICA

Association of Telomere Length of Peripheral Blood Leukocytes With Hematopoietic Relapse, Malignant Transformation, and Survival in Severe Aplastic Anemia

(2010) Phillip Scheinberg et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim

(2009) D. J. Kuter et al.   BLOOD

Effect of the nonpeptide thrombopoietin receptor agonist Eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndrome

(2009) B. Will et al.   BLOOD

Safety and Efficacy of Romiplostim in Patients With Lower-Risk Myelodysplastic Syndrome and Thrombocytopenia

(2009) Hagop Kantarjian et al.   JOURNAL OF CLINICAL ONCOLOGY

Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia

(2008) Phillip Scheinberg et al.   BRITISH JOURNAL OF HAEMATOLOGY

Supportive Care and Use of Hematopoietic Growth Factors in Myelodysplastic Syndromes

(2008) Eva Hellström-Lindberg et al.   SEMINARS IN HEMATOLOGY